Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Gossamer Bio, Inc.
gossamerbio.comAI Executive Summary
AI-powered analysis of 8-K filing content
Gossamer Bio received a Nasdaq compliance notice on April 8, 2026, for failing to maintain the minimum $1.00 per share bid price for 30 consecutive business days, putting the company at risk of delisting and potentially damaging investor confidence.
Key Takeaways
Stock price fell below $1.00 per share for 30+ consecutive business days between February 24 and April 7, 2026
Company is not immediately delisted but must enter a compliance period to regain Nasdaq listing standards
2 more takeaways
Related Filings (1)
1 more filing from Gossamer Bio, Inc. in the last 90 days